SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-064741
Filing Date
2024-03-11
Accepted
2024-03-11 15:19:25
Documents
1
Group Members
MERCK & CO., INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d794405dsc13da.htm SC 13D/A 48141
  Complete submission text file 0001193125-24-064741.txt   50109
Mailing Address ONE MERCK DR PO BOX 100 WS3AB-05 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DR P O BOX 100 WHITEHOUSE STATION NJ 08889-0100 9084231688
MERCK SHARP & DOHME LLC (Filed by) CIK: 0000064978 (see all company filings)

IRS No.: 221109110 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Subject) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90935 | Film No.: 24737727
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)